Phenytoin-induced asterixis - Uncommon or under-diagnozed?

Brain Injury

Volumn 14, Issue 9, 2000, Pages 847-850

  Chi, W M ^a   Chua, K S G ^a   Kong, K H ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; PHENYTOIN;

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; CEREBELLUM DISEASE; COGNITIVE THERAPY; DOSE RESPONSE; DRUG INDUCED DISEASE; FLAPPING TREMOR; GAIT DISORDER; GLASGOW COMA SCALE; HEMIPARESIS; HUMAN; MALE; OCCUPATIONAL THERAPY; PARESTHESIA; PHYSIOTHERAPY; SLURRED SPEECH; SPEECH THERAPY; TONIC CLONIC SEIZURE; VERTIGO;

EID: 0033797029     PISSN: 02699052     EISSN: None     Source Type: Journal    
DOI: 10.1080/026990500421949     Document Type: Article

References (12)

1. A new series of anti-convulsant drugs tested by experiments on animals
2. The neurological changes in the more common types of severe liver disease
3. Asterixis: One type of negative myoclonus
4. Clinical aspects of negative myoclonus
5. Asterixis associated with sodium valproate
6. Anticonvulsant induced dyskinesias - A comparison with dyskinesias induced by neuroleptics
7. Asterixis in focal brain lesions
8. Phenytoin toxicity
9. Postural myoclonus induced by phenytoin
10. Phenytoin toxicity and hepatic encephalopathy: Similation or stimulation?
11. Diphenylhydantoin-induced asterixis. A clinical study
12. Adverse neuropsychiatric effects of anticonvulsant drugs